Nathalie Corvaia

Dr. Nathalie Corvaia


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 November 2024 in Microorganisms
Verified
Journal Article
Open access
PDF file
SBSalomé Biennier
Salomé Biennier
MFMathieu Fontaine
Mathieu Fontaine
ADAurore Duquenoy
Aurore Duquenoy
CSCarole Schwintner
Carole Schwintner
JDJoël Doré
Joël Doré
NCNathalie Corvaia
Nathalie Corvaia
This review explores the complex relationship between gut dysbiosis and hematological malignancies, focusing on graft-versus-host disease (GvHD) in allogeneic hematopoietic stem cell transplantation (allo-HSCT) recipients. We discuss how alterations in microbial diversity and composition can influence disease development, progression, and treatment outcomes in blood cancers. The mechanisms by which the gut microbiota impacts these conditions are examined, including modulation of immune responses, production of metabolites, and effects on intestinal barrier function. Recent advances in microbiome-based therapies for treating and preventing GvHD are highlighted, with emphasis on full ecosystem standardized donor-derived products. Overall, this review underscores the growing importance of microbiome research in hematology–oncology and its potential to complement existing treatments and improve outcomes for thousands of patients worldwide.